{"id":36858,"date":"2026-05-21T15:49:37","date_gmt":"2026-05-21T10:19:37","guid":{"rendered":"https:\/\/atsixty.com\/?p=36858"},"modified":"2026-05-21T15:55:18","modified_gmt":"2026-05-21T10:25:18","slug":"pharmacology-of-l-carnitine","status":"publish","type":"post","link":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/","title":{"rendered":"Pharmacology of L-Carnitine"},"content":{"rendered":"\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&#038;family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&#038;display=swap\" rel=\"stylesheet\">\n<style>\n\/* All styles namespaced to #lcar01 -- no bleed into WordPress theme *\/\n#lcar01 *,#lcar01 *::before,#lcar01 *::after{box-sizing:border-box;margin:0;padding:0}\n#lcar01{\n  --ter:#8B3D20;--ter-light:#B85A38;--ter-pale:#FDF0EB;--ter-dark:#6B2D14;\n  --correct:#2D6B47;--correct-bg:#EAF6EF;--correct-border:#3A9960;\n  --wrong:#B83232;--wrong-bg:#FDF0F0;--wrong-border:#E53935;\n  --ink:#2C1810;--ink-mid:#5A3D30;--ink-soft:#9A7060;\n  --line:#E8DDD8;--cream:#FAF6F2;--warm:#FFFDF9;\n  font-family:'Source Serif 4',Georgia,serif;\n  font-size:16px;color:var(--ink);background:var(--cream);\n  line-height:1.7;padding:0 0 64px;\n}\n#lcar01 .mr-header{background:var(--ter);color:#FFFDF9;padding:34px 24px 28px;text-align:center}\n#lcar01 .mr-eyebrow{font-size:0.68rem;letter-spacing:0.18em;text-transform:uppercase;font-weight:600;opacity:0.65;margin-bottom:10px}\n#lcar01 .mr-title{font-family:'Playfair Display',serif;font-size:1.75rem;font-weight:700;line-height:1.2;margin-bottom:4px}\n#lcar01 .mr-title em{font-style:italic;font-weight:400;opacity:0.88}\n#lcar01 .mr-subtitle{font-size:0.82rem;opacity:0.7;margin-top:8px;font-style:italic}\n#lcar01 .mr-chips{display:flex;justify-content:center;gap:10px;margin-top:18px;flex-wrap:wrap}\n#lcar01 .mr-chip{background:rgba(255,255,255,0.13);border:1px solid rgba(255,255,255,0.22);border-radius:20px;padding:4px 13px;font-size:0.73rem}\n#lcar01 .mr-sentinel{height:1px}\n#lcar01 .mr-progress{position:fixed;top:0;left:0;right:0;z-index:9999;background:var(--warm);border-bottom:1px solid var(--line);box-shadow:0 2px 12px rgba(44,24,16,0.08);padding:9px 16px;display:none}\n#lcar01 .mr-progress.visible{display:block}\n#lcar01 .mr-prog-inner{max-width:720px;margin:0 auto;display:flex;align-items:center;justify-content:center}\n#lcar01 .mr-pips{display:flex;align-items:center;justify-content:center}\n#lcar01 .mr-pip-wrap{display:flex;align-items:center}\n#lcar01 .mr-pip-line{width:28px;height:2px;background:var(--line);transition:background 0.35s}\n#lcar01 .mr-pip-line.done{background:var(--ter)}\n#lcar01 .mr-pip{width:28px;height:28px;border-radius:50%;border:2px solid var(--line);background:var(--warm);display:flex;align-items:center;justify-content:center;font-size:0.63rem;font-weight:700;color:var(--ink-soft);transition:all 0.3s;flex-shrink:0}\n#lcar01 .mr-pip.correct{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#lcar01 .mr-pip.wrong{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#lcar01 .mr-body{max-width:720px;margin:0 auto;padding:0 16px}\n#lcar01 .mr-case{background:var(--warm);border:1px solid var(--line);border-left:4px solid var(--ter);border-radius:10px;margin:28px 0;overflow:hidden;box-shadow:0 1px 6px rgba(44,24,16,0.05)}\n#lcar01 .mr-case-top{padding:16px 20px 14px;display:flex;gap:14px;align-items:flex-start}\n#lcar01 .mr-num{font-family:'Playfair Display',serif;font-size:2.2rem;font-weight:700;color:var(--ter);opacity:0.16;line-height:1;margin-top:-2px;flex-shrink:0}\n#lcar01 .mr-meta{flex:1}\n#lcar01 .mr-tag{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ter);opacity:0.75;margin-bottom:5px}\n#lcar01 .mr-stem{font-size:0.94rem;color:var(--ink);line-height:1.72}\n#lcar01 .mr-stem strong{font-weight:600}\n#lcar01 .mr-stem em{font-style:italic}\n#lcar01 .mr-rule{height:1px;background:var(--line);margin:0 20px}\n#lcar01 .mr-opts{padding:12px 20px 16px;display:flex;flex-direction:column;gap:8px}\n#lcar01 .mr-opt{display:flex;align-items:flex-start;gap:11px;padding:10px 14px;border:1.5px solid var(--line);border-radius:8px;cursor:pointer;background:var(--warm);transition:border-color 0.15s,background 0.15s;-webkit-tap-highlight-color:transparent}\n#lcar01 .mr-opt:hover{border-color:var(--ter);background:var(--ter-pale)}\n#lcar01 .mr-opt.locked{cursor:default}\n#lcar01 .mr-opt.locked:hover{border-color:var(--line);background:var(--warm)}\n#lcar01 .mr-opt.correct{border-color:var(--correct-border);background:var(--correct-bg);cursor:default}\n#lcar01 .mr-opt.correct:hover{border-color:var(--correct-border);background:var(--correct-bg)}\n#lcar01 .mr-opt.wrong{border-color:var(--wrong-border);background:var(--wrong-bg);cursor:default}\n#lcar01 .mr-opt.wrong:hover{border-color:var(--wrong-border);background:var(--wrong-bg)}\n#lcar01 .mr-opt.dimmed{opacity:0.35;cursor:default}\n#lcar01 .mr-opt.dimmed:hover{border-color:var(--line);background:var(--warm)}\n#lcar01 .mr-ltr{flex-shrink:0;width:20px;height:20px;border-radius:50%;border:1.5px solid var(--line);display:flex;align-items:center;justify-content:center;font-size:0.62rem;font-weight:700;color:var(--ink-soft);margin-top:2px;transition:all 0.15s}\n#lcar01 .mr-opt.correct .mr-ltr{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#lcar01 .mr-opt.wrong .mr-ltr{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#lcar01 .mr-opt-text{font-size:0.9rem;color:var(--ink-mid);line-height:1.58}\n#lcar01 .mr-opt.correct .mr-opt-text{color:var(--correct);font-weight:600}\n#lcar01 .mr-opt.wrong .mr-opt-text{color:var(--wrong)}\n#lcar01 .mr-exp{display:none;border-top:1px solid #c8e0d8;background:linear-gradient(180deg,#edf7f4 0%,#f4faf8 100%);padding:13px 20px 15px}\n#lcar01 .mr-exp-lbl{font-size:0.61rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;color:var(--correct);margin-bottom:6px}\n#lcar01 .mr-exp-text{font-size:0.86rem;color:#1c4a3a;line-height:1.68}\n#lcar01 .mr-exp-text strong{font-weight:600}\n#lcar01 .mr-exp-text em{font-style:italic}\n#lcar01 .mr-submit-wrap{text-align:center;padding:28px 16px 8px}\n#lcar01 .mr-btn{background:var(--ter);color:#FFFDF9;border:none;border-radius:8px;padding:13px 44px;font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;cursor:pointer;box-shadow:0 2px 8px rgba(139,61,32,0.28)}\n#lcar01 .mr-btn:hover{background:var(--ter-dark)}\n#lcar01 .mr-score{display:none;background:var(--warm);border:1px solid var(--line);border-top:4px solid var(--ter);border-radius:10px;margin:24px 0 0;box-shadow:0 2px 12px rgba(44,24,16,0.08);overflow:hidden}\n#lcar01 .mr-score-in{padding:28px 24px;text-align:center}\n#lcar01 .mr-score-ey{font-size:0.66rem;letter-spacing:0.14em;text-transform:uppercase;color:var(--ink-soft);margin-bottom:12px;font-weight:600}\n#lcar01 .mr-ring{width:98px;height:98px;border-radius:50%;background:conic-gradient(var(--ter) 0%,var(--line) 0%);display:flex;align-items:center;justify-content:center;margin:0 auto 16px;position:relative}\n#lcar01 .mr-ring::before{content:'';position:absolute;width:76px;height:76px;border-radius:50%;background:var(--warm)}\n#lcar01 .mr-ring-in{position:relative;display:flex;flex-direction:column;align-items:center;line-height:1.2}\n#lcar01 .mr-ring-pct{font-family:'Playfair Display',serif;font-size:1.3rem;font-weight:700;color:var(--ter)}\n#lcar01 .mr-ring-sub{font-size:0.54rem;color:var(--ink-soft);text-transform:uppercase;letter-spacing:0.06em}\n#lcar01 .mr-score-title{font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;color:var(--ink);margin-bottom:4px}\n#lcar01 .mr-score-net{font-size:0.9rem;color:var(--ter);font-weight:600;margin-bottom:4px}\n#lcar01 .mr-verdict{font-size:0.83rem;color:var(--ink-soft);font-style:italic;margin-bottom:18px;padding:0 12px}\n#lcar01 .mr-bands{display:flex;justify-content:center;gap:10px;flex-wrap:wrap}\n#lcar01 .mr-band{padding:5px 13px;border-radius:16px;font-size:0.78rem;font-weight:600}\n#lcar01 .mr-band-c{background:var(--correct-bg);color:var(--correct)}\n#lcar01 .mr-band-w{background:var(--wrong-bg);color:var(--wrong)}\n#lcar01 .mr-band-s{background:var(--ter-pale);color:var(--ter)}\n#lcar01 .mr-retry{display:block;margin:18px auto 4px;background:transparent;border:2px solid var(--ter);color:var(--ter);border-radius:8px;padding:9px 28px;font-family:'Playfair Display',serif;font-size:0.92rem;font-weight:700;cursor:pointer}\n#lcar01 .mr-retry:hover{background:var(--ter);color:#FFFDF9}\n@media(max-width:480px){#lcar01 .mr-title{font-size:1.4rem}#lcar01 .mr-num{font-size:1.7rem}#lcar01 .mr-stem{font-size:0.9rem}#lcar01 .mr-opt-text{font-size:0.86rem}}\n<\/style>\n\n<div id=\"lcar01\">\n\n  <div class=\"mr-header\">\n    <div class=\"mr-eyebrow\">Morning Rounds &middot; Daily Clinical Quiz<\/div>\n    <div class=\"mr-title\">\n      L-Carnitine<br><em>Metabolism &amp; Clinical Pharmacology<\/em>\n    <\/div>\n    <div class=\"mr-subtitle\">Five cases &middot; Read carefully &middot; Trust your instinct<\/div>\n    <div class=\"mr-chips\">\n      <span class=\"mr-chip\">5 Cases<\/span>\n      <span class=\"mr-chip\">+4 \/ &minus;1 scoring<\/span>\n      <span class=\"mr-chip\">Options reshuffled<\/span>\n    <\/div>\n  <\/div>\n\n  <div class=\"mr-sentinel\" id=\"lcar01-sentinel\"><\/div>\n\n  <div class=\"mr-progress\" id=\"lcar01-progress\">\n    <div class=\"mr-prog-inner\">\n      <div class=\"mr-pips\" id=\"lcar01-pips\"><\/div>\n    <\/div>\n  <\/div>\n\n  <div class=\"mr-body\">\n\n    <div id=\"lcar01-cases\"><\/div>\n\n    <div class=\"mr-submit-wrap\">\n      <button class=\"mr-btn\" id=\"lcar01-submit\">Submit for Debrief<\/button>\n    <\/div>\n\n    <div class=\"mr-score\" id=\"lcar01-score\">\n      <div class=\"mr-score-in\">\n        <div class=\"mr-score-ey\">Round Complete<\/div>\n        <div class=\"mr-ring\" id=\"lcar01-ring\">\n          <div class=\"mr-ring-in\">\n            <span class=\"mr-ring-pct\" id=\"lcar01-pct\">0%<\/span>\n            <span class=\"mr-ring-sub\">net<\/span>\n          <\/div>\n        <\/div>\n        <div class=\"mr-score-title\">Your Debrief<\/div>\n        <div class=\"mr-score-net\" id=\"lcar01-net\"><\/div>\n        <div class=\"mr-verdict\" id=\"lcar01-verdict\"><\/div>\n        <div class=\"mr-bands\">\n          <span class=\"mr-band mr-band-c\" id=\"lcar01-ct-c\"><\/span>\n          <span class=\"mr-band mr-band-w\" id=\"lcar01-ct-w\"><\/span>\n          <span class=\"mr-band mr-band-s\" id=\"lcar01-ct-s\"><\/span>\n        <\/div>\n        <button class=\"mr-retry\" id=\"lcar01-retry\">&#8635; New Round<\/button>\n      <\/div>\n    <\/div>\n\n  <\/div>\n<\/div>\n\n<script>\n(function () {\n  'use strict';\n\n  \/* ================================================================\n     NAMESPACE\n     ================================================================ *\/\n  var NS    = 'lcar01';\n  var TOTAL = 5;\n  var MAX   = 20;\n  var LTRS  = ['A','B','C','D'];\n\n  \/* ================================================================\n     QUESTION BANK\n     ================================================================\n     Five questions on L-Carnitine metabolism and clinical use.\n\n     HEADING  : L-Carnitine -- Metabolism & Clinical Pharmacology\n\n     Q1  PRIMARY DEFICIENCY (Medium)\n         Tag     : L-Carnitine -- Primary Deficiency\n         Stem    : 4-year-old girl, proximal weakness, hypoketotic\n                   hypoglycaemia on fasting, lipid myopathy on biopsy,\n                   elevated free carnitine. Enzyme deficient?\n         Answer  : CPT-I on the outer mitochondrial membrane\n         Extra   : CPT-I is the ONLY carnitine disorder with elevated\n                   free carnitine -- acylation step blocked, carnitine\n                   cannot be esterified so it accumulates.\n\n     Q2  NEONATAL DEFECT -- CPT-I vs CPT-II (Hard)\n         Tag     : L-Carnitine -- Neonatal Defect\n         Stem    : 3-day neonate, hypoketotic hypoglycaemia,\n                   hyperammonaemia, elevated free carnitine, low\n                   acylcarnitine. Which defect and why?\n         Answer  : CPT-I -- acyl transfer blocked, free carnitine\n                   accumulates, acylcarnitine remains low\n         Extra   : Hyperammonaemia because acyl-CoA accumulation\n                   inhibits N-acetylglutamate synthase (urea cycle).\n                   Elevated free carnitine = CPT-I. Always.\n\n     Q3  SECONDARY DEFICIENCY -- VALPROATE (Hard)\n         Tag     : L-Carnitine -- Secondary Deficiency\n         Stem    : 9-year-old on valproate, low carnitine, hepatotoxicity.\n                   Primary mechanism of depletion?\n         Answer  : Valproate metabolites conjugate with free carnitine\n                   forming valproylcarnitine esters excreted in urine\n         Extra   : Same principle with pivaloyl-containing antibiotics\n                   (e.g. pivampicillin). L-Carnitine 50-100 mg\/kg\/day\n                   recommended in children on high-dose valproate.\n\n     Q4  POST-MI CARDIAC USE (Easy-Medium)\n         Tag     : L-Carnitine -- Cardiac Pharmacology\n         Stem    : Post-MI patient, EF 40%, started on L-Carnitine\n                   alongside standard therapy. Primary metabolic rationale?\n         Answer  : Restores depleted myocardial carnitine stores to\n                   support LCFA oxidation and limit LV remodelling\n         Extra   : Iliceto et al. trial + 2014 JAMA Internal Medicine\n                   meta-analysis: reduced LV dilation and all-cause\n                   mortality at 5 years post-MI.\n\n     Q5  POST-PPI -- PERMANENT PACEMAKER IMPLANTATION (Medium)\n         Tag     : L-Carnitine -- Post-PPI Rationale\n         Stem    : 61-year-old man, two syncopal episodes over a decade\n                   due to complete heart block, DDDR pacemaker implanted,\n                   no coronary artery disease. Cardiologist prescribes\n                   L-Carnitine 750 mg\/day. Metabolic rationale?\n         Answer  : Recurrent syncope causes brief myocardial\n                   hypoperfusion; carnitine restores fatty acid oxidative\n                   capacity in a heart recovering from intermittent\n                   ischaemic stress\n         Extra   : No effect on pacing threshold, lead integrity, or\n                   nodal automaticity -- those are now managed by the\n                   device. Rationale is cardiometabolic, not electrical.\n                   Dose note: 500 mg OD is a reasonable substitution\n                   if 750 mg is unavailable.\n     ================================================================ *\/\n\n  var QS = [\n\n    \/* ---- Q1 : CPT-I Primary Deficiency ---- *\/\n    {\n      id:      1,\n      tag:     'L-Carnitine &mdash; Primary Deficiency',\n      stem:    'A <strong>4-year-old girl<\/strong> presents with progressive proximal muscle weakness and episodic drowsiness after prolonged fasting. Investigations reveal <strong>hypoketotic hypoglycaemia<\/strong>, elevated serum CK, and hepatomegaly. Muscle biopsy shows excess lipid droplet accumulation. Plasma <em>free<\/em> carnitine is markedly <strong>elevated<\/strong>. The enzyme most likely deficient is:',\n      correct: 'Carnitine palmitoyltransferase-I (CPT-I) on the outer mitochondrial membrane',\n      opts: [\n        'Carnitine palmitoyltransferase-I (CPT-I) on the outer mitochondrial membrane',\n        'Carnitine palmitoyltransferase-II (CPT-II) on the inner mitochondrial membrane',\n        'Carnitine-acylcarnitine translocase (CAAT) within the inner membrane',\n        'Medium-chain acyl-CoA dehydrogenase (MCAD) in the mitochondrial matrix'\n      ],\n      exp:     '<strong>CPT-I<\/strong> sits on the <em>outer<\/em> mitochondrial membrane and catalyses the first step of the carnitine shuttle: transfer of the long-chain acyl group from acyl-CoA onto free carnitine, forming acylcarnitine. When CPT-I is deficient this step is blocked &mdash; long-chain fatty acids cannot enter the mitochondria, and free carnitine <em>accumulates<\/em> because it cannot be esterified. <strong>Elevated free carnitine is the pathognomonic finding that distinguishes CPT-I deficiency from all other carnitine disorders<\/strong>, where free carnitine is typically low or normal. Failure of beta-oxidation explains the lipid myopathy, hypoketotic hypoglycaemia on fasting, and hepatic steatosis. <strong>Exam trap:<\/strong> MCAD deficiency involves medium-chain FAs (C6&ndash;C12) which do not use the carnitine shuttle at all.'\n    },\n\n    \/* ---- Q2 : CPT-I vs CPT-II Neonatal ---- *\/\n    {\n      id:      2,\n      tag:     'L-Carnitine &mdash; Neonatal Defect',\n      stem:    'A <strong>3-day-old neonate<\/strong> presents with lethargy, poor feeding, and seizures. Investigations show hypoketotic hypoglycaemia and hyperammonaemia. Plasma carnitine profile: markedly <strong>elevated free carnitine<\/strong>, very low acylcarnitine. Urine organic acids are unremarkable. Which statement correctly identifies the defect and explains the carnitine profile?',\n      correct: 'CPT-I deficiency: acyl transfer to carnitine is blocked at the outer membrane, so free carnitine accumulates and acylcarnitine remains low',\n      opts: [\n        'CPT-I deficiency: acyl transfer to carnitine is blocked at the outer membrane, so free carnitine accumulates and acylcarnitine remains low',\n        'CPT-II deficiency: acylcarnitine cannot be reconverted to acyl-CoA at the inner membrane, so acylcarnitines accumulate and free carnitine falls',\n        'Carnitine transporter (OCTN2) defect: urinary carnitine wasting depletes both free and acylcarnitine fractions equally',\n        'Primary systemic carnitine deficiency: reduced dietary intake causes symmetrically low free and acyl fractions'\n      ],\n      exp:     'The plasma carnitine <em>profile<\/em> is the key discriminator. In <strong>CPT-I deficiency<\/strong>, the outer-membrane acylation step fails &mdash; free carnitine cannot be esterified into acylcarnitine, so <strong>free carnitine rises<\/strong> and acylcarnitine falls. This is the <em>only<\/em> carnitine disorder with elevated free carnitine. In <strong>CPT-II deficiency<\/strong> (inner membrane), acylcarnitines enter the matrix but cannot be reconverted to acyl-CoA &mdash; <strong>acylcarnitines accumulate<\/strong> and free carnitine is low. In <strong>OCTN2 transporter defect<\/strong>, carnitine is lost in urine, causing a global fall in both fractions. <strong>Extra point:<\/strong> hyperammonaemia in CPT-I occurs because accumulated acyl-CoA species inhibit N-acetylglutamate synthase &mdash; the rate-limiting enzyme of the urea cycle. <strong>Rule:<\/strong> elevated free carnitine = CPT-I, no exceptions among carnitine shuttle disorders.'\n    },\n\n    \/* ---- Q3 : Valproate Secondary Deficiency ---- *\/\n    {\n      id:      3,\n      tag:     'L-Carnitine &mdash; Secondary Deficiency',\n      stem:    'A <strong>9-year-old boy<\/strong> on valproate <strong>30 mg\/kg\/day<\/strong> for generalised epilepsy develops fatigue, anorexia, and mildly elevated transaminases after three years of treatment. Serum carnitine is low. Secondary carnitine deficiency is diagnosed. The primary mechanism of depletion is:',\n      correct: 'Valproate metabolites conjugate with free carnitine to form valproylcarnitine esters, which are excreted in urine causing net carnitine wasting',\n      opts: [\n        'Valproate metabolites conjugate with free carnitine to form valproylcarnitine esters, which are excreted in urine causing net carnitine wasting',\n        'Valproate directly inhibits CPT-II on the inner mitochondrial membrane, blocking acylcarnitine entry',\n        'Valproate causes renal tubular acidosis with non-selective aminoaciduria including carnitine',\n        'Valproate suppresses endogenous carnitine biosynthesis by inhibiting trimethyllysine hydroxylase in the liver'\n      ],\n      exp:     'Valproate undergoes beta-oxidation and omega-oxidation in the liver, generating acyl-CoA metabolites &mdash; principally valproyl-CoA and its derivatives. These conjugate with <strong>free carnitine<\/strong> to form valproylcarnitine esters, which are excreted renally. The net result is progressive <strong>urinary carnitine wasting<\/strong> and secondary deficiency that impairs fatty acid oxidation. This mechanism underlies the hepatotoxicity, hyperammonaemia (via urea cycle inhibition), and the rare but severe <strong>valproate-induced Reye-like syndrome<\/strong>. <strong>Extra point:<\/strong> L-Carnitine 50&ndash;100 mg\/kg\/day is recommended in children on high-dose valproate when serum carnitine is low or symptoms appear. The same mechanism applies to <strong>pivaloyl-containing antibiotics<\/strong> (e.g. pivampicillin) &mdash; another classic iatrogenic cause of secondary carnitine deficiency that appears in examinations.'\n    },\n\n    \/* ---- Q4 : Post-MI Cardiac Pharmacology ---- *\/\n    {\n      id:      4,\n      tag:     'L-Carnitine &mdash; Cardiac Pharmacology',\n      stem:    'A <strong>58-year-old man<\/strong> recovering from an acute anterior wall myocardial infarction is commenced on L-Carnitine 500 mg twice daily at discharge, alongside dual antiplatelet therapy, a statin, a beta-blocker, and an ACE inhibitor. Echocardiography shows EF 40% with anterior wall hypokinesia. The primary metabolic rationale for adding L-Carnitine in this setting is:',\n      correct: 'Restoration of depleted myocardial carnitine stores to support long-chain fatty acid oxidation in the peri-ischaemic zone and limit ventricular remodelling',\n      opts: [\n        'Restoration of depleted myocardial carnitine stores to support long-chain fatty acid oxidation in the peri-ischaemic zone and limit ventricular remodelling',\n        'Inhibition of platelet aggregation to reduce the risk of in-stent thrombosis alongside antiplatelets',\n        'Reduction of LDL cholesterol by a mechanism complementary to statin-induced HMG-CoA reductase inhibition',\n        'Prevention of contrast-induced nephropathy following coronary angiography'\n      ],\n      exp:     'Under normal conditions the heart derives approximately <strong>70% of its ATP from long-chain fatty acid (LCFA) oxidation<\/strong> &mdash; a process entirely dependent on the carnitine shuttle. Ischaemia acutely depletes myocardial free carnitine and causes toxic accumulation of long-chain acyl-CoA species, disrupting membrane integrity and impairing contractile recovery. L-Carnitine supplementation restores shuttle capacity and reduces the acyl-CoA burden. <strong>Evidence base:<\/strong> the <em>Iliceto et al.<\/em> trial and the 2014 JAMA Internal Medicine meta-analysis demonstrated that post-MI carnitine supplementation significantly reduced left ventricular dilation and all-cause mortality at 5 years. The effect is entirely metabolic and structural &mdash; <strong>L-Carnitine has no antithrombotic, lipid-lowering, or renoprotective action<\/strong>. <strong>Exam note:<\/strong> L-Carnitine is adjunctive &mdash; it does not substitute for any element of standard post-MI therapy.'\n    },\n\n    \/* ---- Q5 : Post-PPI (Permanent Pacemaker Implantation) ---- *\/\n    {\n      id:      5,\n      tag:     'L-Carnitine &mdash; Post-PPI Rationale',\n      stem:    'A <strong>61-year-old man<\/strong> has had two syncopal episodes over a decade, both attributed to intermittent <strong>complete heart block<\/strong>. He undergoes <strong>permanent pacemaker implantation (DDDR mode)<\/strong>. There is no history of coronary artery disease. His cardiologist prescribes L-Carnitine 750 mg\/day as part of the post-procedure regimen. The most appropriate metabolic rationale for this prescription is:',\n      correct: 'Recurrent syncopal episodes cause brief myocardial hypoperfusion; carnitine supports restoration of fatty acid oxidative capacity in a heart recovering from intermittent ischaemic stress',\n      opts: [\n        'Recurrent syncopal episodes cause brief myocardial hypoperfusion; carnitine supports restoration of fatty acid oxidative capacity in a heart recovering from intermittent ischaemic stress',\n        'L-Carnitine lowers the pacemaker stimulation threshold, reducing the energy required per pacing impulse',\n        'L-Carnitine prevents pacemaker lead thrombosis through its anticoagulant and antiplatelet properties',\n        'L-Carnitine enhances sino-atrial node automaticity, reducing the proportion of paced beats and promoting intrinsic rhythm recovery'\n      ],\n      exp:     'Complete heart block causes abrupt loss of cardiac output during each syncopal episode. Even brief cessation of myocardial perfusion &mdash; lasting seconds to minutes &mdash; is sufficient to deplete <strong>free carnitine stores<\/strong> in the myocardium, impairing the carnitine shuttle and shifting the heart toward less efficient anaerobic metabolism. Repeated episodes over years compound this depletion. L-Carnitine supplementation restores long-chain fatty acid oxidative capacity and reduces the acyl-CoA accumulation that follows each ischaemic insult. It has <strong>no direct effect on pacing threshold, lead integrity, or nodal automaticity<\/strong> &mdash; those are now managed by the device. <strong>Extra point:<\/strong> the indication here is <em>cardiometabolic support<\/em> for a myocardium subjected to recurrent haemodynamic stress. The mechanism is analogous to post-MI use but the precipitant is electrical (heart block) rather than atherosclerotic (coronary obstruction). <em>Dose note:<\/em> if 750 mg is unavailable, 500 mg OD is a clinically reasonable substitution pending the next cardiology review.'\n    }\n\n  ];\n  \/* ================================================================\n     END OF CONTENT\n     All code below this line is engine logic -- do not edit.\n     ================================================================ *\/\n\n\n  var answers  = {};\n  var answered = 0;\n  var shuffled = {};\n  var done     = false;\n\n  function byId(id)    { return document.getElementById(id); }\n  function gid(sfx)    { return byId(NS + '-' + sfx); }\n\n  \/* Fisher-Yates shuffle *\/\n  function shuffleArr(arr) {\n    var a = arr.slice(), i, j, t;\n    for (i = a.length - 1; i > 0; i--) {\n      j = Math.floor(Math.random() * (i + 1));\n      t = a[i]; a[i] = a[j]; a[j] = t;\n    }\n    return a;\n  }\n\n  function countVal(val) {\n    var k, n = 0;\n    for (k in answers) {\n      if (answers.hasOwnProperty(k) && answers[k] === val) n++;\n    }\n    return n;\n  }\n\n  function buildPips() {\n    var cont = gid('pips'), i, q, wl, wp, line, pip;\n    if (!cont) return;\n    cont.innerHTML = '';\n    for (i = 0; i < QS.length; i++) {\n      q = QS[i];\n      if (i > 0) {\n        wl = document.createElement('div'); wl.className = 'mr-pip-wrap';\n        line = document.createElement('div'); line.className = 'mr-pip-line';\n        line.id = NS + '-pl' + q.id;\n        wl.appendChild(line); cont.appendChild(wl);\n      }\n      wp = document.createElement('div'); wp.className = 'mr-pip-wrap';\n      pip = document.createElement('div'); pip.className = 'mr-pip';\n      pip.id = NS + '-pip' + q.id; pip.textContent = String(q.id);\n      wp.appendChild(pip); cont.appendChild(wp);\n    }\n  }\n\n  function build() {\n    var cont, i, q, opts, card, top, nd, meta, tg, st,\n        rule, od, ed, lb, tx, j, oe, ls, ts;\n\n    cont = gid('cases');\n    if (!cont) return;\n    cont.innerHTML = '';\n    answers = {}; answered = 0; shuffled = {}; done = false;\n    if (gid('score')) gid('score').style.display = 'none';\n    buildPips();\n\n    for (i = 0; i < QS.length; i++) {\n      q = QS[i];\n      opts = shuffleArr(q.opts);\n      shuffled[q.id] = opts;\n\n      card = document.createElement('div'); card.className = 'mr-case';\n\n      top = document.createElement('div'); top.className = 'mr-case-top';\n\n      nd = document.createElement('div'); nd.className = 'mr-num';\n      nd.textContent = q.id < 10 ? '0' + q.id : String(q.id);\n\n      meta = document.createElement('div'); meta.className = 'mr-meta';\n\n      tg = document.createElement('div'); tg.className = 'mr-tag';\n      tg.innerHTML = q.tag;\n\n      st = document.createElement('div'); st.className = 'mr-stem';\n      st.innerHTML = q.stem;\n\n      meta.appendChild(tg); meta.appendChild(st);\n      top.appendChild(nd); top.appendChild(meta);\n      card.appendChild(top);\n\n      rule = document.createElement('div'); rule.className = 'mr-rule';\n      card.appendChild(rule);\n\n      od = document.createElement('div'); od.className = 'mr-opts';\n\n      for (j = 0; j < opts.length; j++) {\n        oe = document.createElement('div'); oe.className = 'mr-opt';\n        oe.id = NS + '-o' + q.id + '-' + j;\n        oe.setAttribute('role', 'button'); oe.setAttribute('tabindex', '0');\n\n        ls = document.createElement('span'); ls.className = 'mr-ltr';\n        ls.textContent = LTRS[j];\n\n        ts = document.createElement('span'); ts.className = 'mr-opt-text';\n        ts.innerHTML = opts[j];\n\n        oe.appendChild(ls); oe.appendChild(ts);\n        od.appendChild(oe);\n\n        (function (qid, oi) {\n          oe.addEventListener('click', function () { pick(qid, oi); });\n        }(q.id, j));\n      }\n      card.appendChild(od);\n\n      ed = document.createElement('div'); ed.className = 'mr-exp';\n      ed.id = NS + '-exp' + q.id;\n\n      lb = document.createElement('div'); lb.className = 'mr-exp-lbl';\n      lb.textContent = 'Debrief';\n\n      tx = document.createElement('div'); tx.className = 'mr-exp-text';\n      tx.innerHTML = q.exp;\n\n      ed.appendChild(lb); ed.appendChild(tx);\n      card.appendChild(ed);\n      cont.appendChild(card);\n    }\n  }\n\n  function pick(qid, oi) {\n    var q, opts, i, el, isCorrect;\n    if (answers[qid] !== undefined || done) return;\n\n    q = null;\n    for (i = 0; i < QS.length; i++) {\n      if (QS[i].id === qid) { q = QS[i]; break; }\n    }\n    if (!q) return;\n\n    opts = shuffled[qid];\n    isCorrect = (opts[oi] === q.correct);\n    answers[qid] = isCorrect ? 'c' : 'w';\n    answered++;\n\n    for (i = 0; i < opts.length; i++) {\n      el = byId(NS + '-o' + qid + '-' + i);\n      if (!el) continue;\n      if (opts[i] === q.correct) {\n        el.className = 'mr-opt correct locked';\n      } else if (i === oi) {\n        el.className = 'mr-opt wrong locked';\n      } else {\n        el.className = 'mr-opt dimmed locked';\n      }\n    }\n\n    var expEl = byId(NS + '-exp' + qid);\n    if (expEl) expEl.style.display = 'block';\n\n    var pip = byId(NS + '-pip' + qid);\n    if (pip) pip.className = 'mr-pip ' + (isCorrect ? 'correct' : 'wrong');\n\n    if (qid > 1) {\n      var pl = gid('pl' + qid);\n      if (pl) pl.className = 'mr-pip-line done';\n    }\n  }\n\n  function showScore() {\n    var c, w, s, net, pct, disp, vlist, vi, sc;\n    if (done) return;\n    done = true;\n\n    c    = countVal('c');\n    w    = countVal('w');\n    s    = TOTAL - answered;\n    net  = c * 4 - w;\n    pct  = Math.max(0, Math.round((net \/ MAX) * 100));\n    disp = Math.min(100, Math.max(0, pct));\n\n    var ring = gid('ring');\n    if (ring) ring.style.background =\n      'conic-gradient(#8B3D20 ' + disp + '%, #E8DDD8 0%)';\n\n    var pe = gid('pct'); if (pe) pe.textContent = pct + '%';\n    var ne = gid('net'); if (ne) ne.textContent = 'Net Score: ' + net + ' \/ ' + MAX;\n\n    vlist = [\n      [5, 'Perfect round. The carnitine shuttle holds no secrets from you.'],\n      [4, 'Strong \\u2014 one nuance to revisit before exam day.'],\n      [3, 'Solid base \\u2014 consolidate the harder distinctions.'],\n      [2, 'Halfway there \\u2014 the debrief panels repay careful reading.'],\n      [0, 'These cases are worth revisiting. Come back tomorrow.']\n    ];\n    var ve = gid('verdict');\n    if (ve) {\n      ve.textContent = vlist[4][1];\n      for (vi = 0; vi < vlist.length; vi++) {\n        if (c >= vlist[vi][0]) { ve.textContent = vlist[vi][1]; break; }\n      }\n    }\n\n    var cc = gid('ct-c'); if (cc) cc.textContent = '\\u2705 ' + c + ' Correct';\n    var cw = gid('ct-w'); if (cw) cw.textContent = '\\u274C ' + w + ' Wrong';\n    var cs = gid('ct-s'); if (cs) cs.textContent = '\\u23ED ' + s + ' Skipped';\n\n    sc = gid('score');\n    if (sc) {\n      sc.style.display = 'block';\n      sc.scrollIntoView({ behavior: 'smooth', block: 'center' });\n    }\n  }\n\n  function initObserver() {\n    var sentinel = gid('sentinel'), bar = gid('progress');\n    if (!sentinel || !bar || !window.IntersectionObserver) return;\n    new IntersectionObserver(function (entries) {\n      bar.className = entries[0].isIntersecting\n        ? 'mr-progress'\n        : 'mr-progress visible';\n    }, { threshold: 0 }).observe(sentinel);\n  }\n\n  function init() {\n    var sb = gid('submit'), rb = gid('retry');\n    if (!sb || !rb) return;\n    sb.addEventListener('click', showScore);\n    rb.addEventListener('click', function () { build(); window.scrollTo(0, 0); });\n    initObserver();\n    build();\n  }\n\n  \/* Polling init -- retries every 50 ms until the target div exists.\n     Required for WordPress where scripts may execute before the DOM\n     fragment is fully inserted by the block editor. *\/\n  function tryInit(n) {\n    if (document.getElementById('lcar01-cases')) {\n      init();\n    } else if (n < 40) {\n      setTimeout(function () { tryInit(n + 1); }, 50);\n    }\n  }\n\n  tryInit(0);\n\n}());\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds &middot; Daily Clinical Quiz L-CarnitineMetabolism &amp; Clinical Pharmacology Five cases &middot; Read carefully &middot; Trust your instinct 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635; New Round<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-36858","post","type-post","status-publish","format-standard","hentry","category-neet-pg"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmacology of L-Carnitine - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacology of L-Carnitine - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds &middot; Daily Clinical Quiz L-CarnitineMetabolism &amp; Clinical Pharmacology Five cases &middot; Read carefully &middot; Trust your instinct 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635; New Round\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-21T10:19:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-21T10:25:18+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Pharmacology of L-Carnitine\",\"datePublished\":\"2026-05-21T10:19:37+00:00\",\"dateModified\":\"2026-05-21T10:25:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/\"},\"wordCount\":38,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"articleSection\":[\"NEET PG\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/\",\"name\":\"Pharmacology of L-Carnitine - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-05-21T10:19:37+00:00\",\"dateModified\":\"2026-05-21T10:25:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/2026\\\/05\\\/21\\\/pharmacology-of-l-carnitine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacology of L-Carnitine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacology of L-Carnitine - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacology of L-Carnitine - atsixty","og_description":"Morning Rounds &middot; Daily Clinical Quiz L-CarnitineMetabolism &amp; Clinical Pharmacology Five cases &middot; Read carefully &middot; Trust your instinct 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635; New Round","og_url":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/","og_site_name":"atsixty","article_published_time":"2026-05-21T10:19:37+00:00","article_modified_time":"2026-05-21T10:25:18+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Pharmacology of L-Carnitine","datePublished":"2026-05-21T10:19:37+00:00","dateModified":"2026-05-21T10:25:18+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/"},"wordCount":38,"commentCount":0,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"articleSection":["NEET PG"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/","url":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/","name":"Pharmacology of L-Carnitine - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-05-21T10:19:37+00:00","dateModified":"2026-05-21T10:25:18+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/2026\/05\/21\/pharmacology-of-l-carnitine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Pharmacology of L-Carnitine"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/36858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=36858"}],"version-history":[{"count":3,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/36858\/revisions"}],"predecessor-version":[{"id":36861,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/36858\/revisions\/36861"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=36858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=36858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=36858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}